The Maine Cancer Genomics Initiative (MCGI) is a statewide collaboration that brings cancer genomic testing, education and drug access infrastructure to Maine.
Settings
Save and close
The Maine Cancer Genomics Initiative (MCGI) is a statewide collaboration that brings cancer genomic testing, education and drug access infrastructure to Maine.
Clinical trials for cancer are research studies that compare the standard treatment for a specific type or stage of cancer with a new approach. This can be a new drug, a combination of drugs or a different way of using established therapies. There are clinical trials for every major type of cancer. While many trials focus on late-stage disease, there are also trials to prevent cancer, improve early diagnosis, prevent cancer from returning, reduce side effects or improve quality of life. MCGI is working to increase the options for clinical trials for cancer patients in Maine.
If you want to learn more about clinical trials, please visit the Ochsner Health Research page.
Answer a few questions after visiting Leal Health’s site linked below and see personalized results of trials you may be eligible for. If no trials are available, their system will continue to search and alert you if a match is made.
Strengthen your understanding of a patient's genetic construct to make more informed decisions on treatment, ultimately leading to enhanced outcomes and prognosis.
View more
Utilize the JAX APML to advance your research and keep driving towards tomorrow's discovery.
View more